zinc supplementation; Ulcerative colitis
Phase 3
Recruiting
- Conditions
- ulcerative colitis disease.Ulcerative colitis, unspecifiedK51.9
- Registration Number
- IRCT20190712044182N3
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Body mass index between 18.5 and 35
?Diagnosis of ulcerative colitis according to the patient's symptoms, tests and colonoscopy, and intestinal sample pathology
Mild to moderate active form of the disease according to the Mayo questionnaire
Absence of concomitant diseases
not taking supplements containing zinc during the last 2 months
No use of infliximab, Sinora, high dose of corticosteroids (above 40 mg), NSAIDs
Not pregnant or lactating
Not taking contraceptives
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of clinical symptoms. Timepoint: At the baseline (before the start of the intervention) and at the end of the intervention (60 days after taking zinc or placebo). Method of measurement: Mayo questionnaire.
- Secondary Outcome Measures
Name Time Method